معرفی
Professor David Paterson is an Honorary Professor at The University of Queensland Centre for Clinical Research (UQCCR) and serves as Director of UQCCR. He concurrently holds a position as Consultant Infectious Diseases Physician at the Royal Brisbane and Women's Hospital, Australia's largest hospital and a top 100 global institution. His career spans over two decades with significant contributions to infectious diseases research and clinical practice.
Professor Paterson received both his medical degree and PhD from The University of Queensland. After ten years at The University of Pittsburgh School of Medicine, he returned to Brisbane in 2007, where he quickly established himself as a leading researcher in antimicrobial resistance.
His research focuses on the molecular and clinical epidemiology of infections with antibiotic-resistant organisms, with emphasis on translating knowledge into optimal prevention and treatment strategies. His work encompasses antimicrobial resistance mechanisms, clinical trial design for novel antibiotics, bloodstream infection management, and diagnostic stewardship. Recent work includes the MERINO trial (world's largest trial on antibiotics for ESBL-producing bacterial infections) and leadership in global antimicrobial resistance surveillance initiatives.
Analysis of his recent publications reveals dominant themes in antimicrobial resistance (particularly carbapenem-resistant organisms), diagnostic testing innovations, clinical trial methodology, and real-world antibiotic effectiveness studies. His work spans laboratory-based molecular research through to large multinational clinical trials and epidemiological studies.
- ISI Thomson Reuters Highly Cited List annually (2015-2019)
- Frank Fenner Award for Advanced Research in Infectious Diseases (2008)
- Queensland Health Senior Clinical Research Fellowship (2009)
- Multiple NHMRC Practitioner Fellowships
- NHMRC Investigator Grant holder
Professor Paterson has secured substantial research funding from diverse sources including the Centers for Disease Control and Prevention (CDC), Australia's National Health and Medical Research Council (NHMRC), and the Medical Research Future Fund. He has supervised numerous researchers and students, contributing to the development of Australia's infectious diseases research capacity. His leadership extends to major collaborative networks including the MERINO trial consortium and global antimicrobial resistance surveillance initiatives.
